News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
433,238 Results
Type
Article (26098)
Company Profile (124)
Press Release (407016)
Section
Business (136624)
Career Advice (1191)
Deals (24668)
Drug Delivery (84)
Drug Development (56135)
Employer Resources (105)
FDA (9870)
Job Trends (9460)
News (231987)
Policy (21161)
Tag
Academia (1485)
Alliances (34354)
Alzheimer's disease (751)
Approvals (9881)
Artificial intelligence (140)
Bankruptcy (205)
Best Places to Work (7161)
Breast cancer (134)
Cancer (973)
Cardiovascular disease (88)
Career advice (1012)
Cell therapy (186)
Clinical research (46367)
Collaboration (417)
Compensation (137)
COVID-19 (1689)
C-suite (133)
Data (1006)
Diabetes (154)
Diagnostics (3287)
Drug pricing (77)
Earnings (51597)
Employer resources (96)
Events (59539)
Executive appointments (474)
FDA (10436)
Funding (373)
Gene therapy (160)
GLP-1 (494)
Government (2430)
Healthcare (9865)
Infectious disease (1758)
Inflammatory bowel disease (98)
Interviews (177)
IPO (10081)
Job creations (2610)
Job search strategy (907)
Layoffs (257)
Legal (5135)
Lung cancer (125)
Manufacturing (187)
Medical device (6023)
Medtech (6027)
Mergers & acquisitions (14863)
Metabolic disorders (397)
Neuroscience (1023)
NextGen: Class of 2025 (3640)
Non-profit (2233)
Northern California (1106)
Obesity (214)
Opinion (159)
Patents (117)
People (43326)
Phase I (12618)
Phase II (20167)
Phase III (16926)
Pipeline (499)
Postmarket research (1904)
Preclinical (5014)
Radiopharmaceuticals (168)
Rare diseases (230)
Real estate (3806)
Regulatory (14751)
Research institute (1405)
Resumes & cover letters (151)
Series A (76)
Southern California (1041)
Startups (2543)
United States (10532)
Vaccines (407)
Weight loss (149)
Date
Last 7 days (464)
Last 30 days (1580)
Last 365 days (20703)
2025 (3200)
2024 (21316)
2023 (24097)
2022 (32798)
2021 (34928)
2020 (33357)
2019 (27967)
2018 (21613)
2017 (22095)
2016 (21340)
2015 (25083)
2014 (19484)
2013 (16199)
2012 (17466)
2011 (18207)
2010 (16373)
Location
Africa (520)
Arizona (87)
Asia (35826)
Australia (5185)
California (2572)
Canada (1195)
China (309)
Colorado (133)
Connecticut (115)
Europe (65481)
Florida (404)
Georgia (113)
Illinois (276)
Indiana (202)
Japan (108)
Maryland (455)
Massachusetts (1990)
Minnesota (173)
New Jersey (976)
New York (811)
North Carolina (511)
Northern California (1106)
Ohio (86)
Pennsylvania (614)
South America (807)
Southern California (1041)
Texas (371)
Virginia (83)
Washington State (238)
433,238 Results for "sihuan pharmaceutical holdings group ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioCapital
Vanda Pharmaceuticals Confirms Receipt of Unsolicited, Non-Binding Indication of Interest from Cycle Group Holdings Ltd.
Vanda Pharmaceuticals Inc. confirmed that it has received an unsolicited, non-binding indication of interest from Cycle Group Holdings Ltd. to acquire the Company for $8.00 per share in cash.
June 6, 2024
·
3 min read
Sihuan Pharmaceutical Was Selected As One Of The First Echelon Of Enterprises In The list of China’s Top 100 Pharmaceutical Innovative Enterprises in 2023
Sihuan Pharmaceutical Holdings Group Ltd. is pleased to announce that the “Group” was selected as one of the first echelon of enterprises in The list of China’s Top 100 Pharmaceutical Innovative Enterprises in 2023.
October 14, 2023
·
2 min read
Press Releases
Basel Medical Group Ltd Prices US$8,820,000 Initial Public Offering
February 26, 2025
·
5 min read
Press Releases
Vanda Pharmaceuticals Confirms Receipt of Economically Identical Unsolicited, Non-Binding Proposal from Cycle Group Holdings Ltd.
October 15, 2024
·
3 min read
Press Releases
Qilian International Holding Group Ltd. Announces Trading Ticker Symbol to “BGM”
August 13, 2024
·
2 min read
Xuanzhu Biopharm, a subsidiary of Sihuan Pharmaceutical, Its Innovative Drug Anaprozole Sodium Enteric-coated Tablets Obtains Drug Registration Approval From NMPA
Sihuan Pharmaceutical Holdings Group Ltd. together with its subsidiaries, is pleased to announce that Xuanzhu Biopharmaceutical Co., Ltd., a non-wholly owned subsidiary of Company, has received a drug registration approval from the National Medical Products Administration of China of Anaprozole Sodium Enteric-coated Tablet for the treatment of duodenal ulcer.
June 27, 2023
·
5 min read
Press Releases
Lakeside Holding Enters Medical Logistics Sector with Acquisition of Hupan Pharmaceutical (Hubei) Co., Ltd.
November 11, 2024
·
4 min read
Press Releases
WORK Medical Technology Group LTD’s Subsidiary, Hangzhou Shanyou, Showcases Products at MEDICA Trade Fair 2024
November 28, 2024
·
4 min read
Press Releases
Predictive Oncology Partners with Switzerland-Based Tecan Group Ltd. to Expand High-Throughput Drug Screening to Include Human Tumor Spheroids Using Automated Imaging and 3D Analysis
February 10, 2025
·
5 min read
Press Releases
Qilian International Holding Group Ltd Regained Compliance with Nasdaq’s Minimum Bid Price Rule
July 15, 2024
·
2 min read
1 of 43,324
Next
